Jen‐Chih Tseng

552 total citations
16 papers, 375 citations indexed

About

Jen‐Chih Tseng is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Jen‐Chih Tseng has authored 16 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Immunology and Allergy. Recurrent topics in Jen‐Chih Tseng's work include Immune cells in cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Influenza Virus Research Studies (2 papers). Jen‐Chih Tseng is often cited by papers focused on Immune cells in cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Influenza Virus Research Studies (2 papers). Jen‐Chih Tseng collaborates with scholars based in Taiwan, China and United States. Jen‐Chih Tseng's co-authors include Chih‐Pin Chuu, Ching‐Yu Lin, Jingxing Yang, Tsung‐Hsien Chuang, Shih‐Han Huang, Yi‐Ren Hong, Chi‐Ying F. Huang, Guann‐Yi Yu, Yunping Luo and Shiaw‐Der Yang and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Cell Death and Disease.

In The Last Decade

Jen‐Chih Tseng

15 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jen‐Chih Tseng Taiwan 11 156 104 73 52 46 16 375
Maralee McVean United States 9 209 1.3× 66 0.6× 37 0.5× 49 0.9× 36 0.8× 16 479
Darryl Johnson United States 13 284 1.8× 36 0.3× 29 0.4× 31 0.6× 72 1.6× 17 525
Hyung Keun Kim South Korea 10 285 1.8× 90 0.9× 27 0.4× 17 0.3× 37 0.8× 14 509
Rouba Hage‐Sleiman Lebanon 11 153 1.0× 29 0.3× 35 0.5× 35 0.7× 35 0.8× 15 308
Kyung‐Don Kang United States 13 297 1.9× 60 0.6× 105 1.4× 82 1.6× 12 0.3× 30 562
Munehiro Teranishi Japan 13 154 1.0× 99 1.0× 19 0.3× 39 0.8× 50 1.1× 40 471
Laurent Martin France 13 218 1.4× 156 1.5× 130 1.8× 33 0.6× 23 0.5× 27 853
Xiaoxian Gan China 12 277 1.8× 62 0.6× 75 1.0× 67 1.3× 34 0.7× 21 566
Zhaohui Meng China 13 304 1.9× 26 0.3× 56 0.8× 44 0.8× 48 1.0× 36 538
Maria Fernanda de Souza Costa Brazil 12 162 1.0× 260 2.5× 19 0.3× 103 2.0× 21 0.5× 18 560

Countries citing papers authored by Jen‐Chih Tseng

Since Specialization
Citations

This map shows the geographic impact of Jen‐Chih Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen‐Chih Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen‐Chih Tseng more than expected).

Fields of papers citing papers by Jen‐Chih Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jen‐Chih Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen‐Chih Tseng. The network helps show where Jen‐Chih Tseng may publish in the future.

Co-authorship network of co-authors of Jen‐Chih Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Jen‐Chih Tseng. A scholar is included among the top collaborators of Jen‐Chih Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen‐Chih Tseng. Jen‐Chih Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tseng, Jen‐Chih, Jingxing Yang, Yiling Liu, et al.. (2024). Cooperative tumor inhibition by CpG-oligodeoxynucleotide and cyclic dinucleotide in head and neck cancer involves T helper cytokine and macrophage phenotype reprogramming. Biomedicine & Pharmacotherapy. 181. 117692–117692.
2.
Yang, Jingxing, Yu-Chen Chuang, Jen‐Chih Tseng, et al.. (2024). Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation. Journal of Experimental & Clinical Cancer Research. 43(1). 169–169. 7 indexed citations
3.
Tseng, Jen‐Chih, Jingxing Yang, Chia‐Yin Lee, et al.. (2023). Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. International Journal of Biological Sciences. 19(9). 2648–2662. 4 indexed citations
4.
Yang, Jingxing, Jen‐Chih Tseng, Chia‐Yin Lee, et al.. (2023). TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses. International Journal of Biological Sciences. 19(9). 2897–2913. 10 indexed citations
5.
Tseng, Jen‐Chih, Jen‐Kun Chen, Tzyh‐Chyuan Hour, et al.. (2023). Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells. Phytomedicine. 116. 154860–154860. 16 indexed citations
6.
7.
Yang, Jingxing, Jen‐Chih Tseng, Guann‐Yi Yu, et al.. (2022). Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics. 14(2). 423–423. 77 indexed citations
8.
Tseng, Jen‐Chih, Jingxing Yang, Yiling Liu, et al.. (2021). Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide. Cancer Immunology Immunotherapy. 71(5). 1115–1128. 12 indexed citations
9.
Tseng, Jen‐Chih, Shih‐Han Huang, Ching‐Yu Lin, et al.. (2020). ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p–PIAS3–AKT2 signaling axis. Cell Death and Disease. 11(5). 376–376. 30 indexed citations
10.
Chuu, Chih‐Pin, et al.. (2017). Non-Canonical Wnt Receptor ROR2 Suppresses Prostate Cancer Metastasis. Annals of Oncology. 28. ix102–ix102. 1 indexed citations
11.
Tseng, Jen‐Chih, et al.. (2017). Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency. Oncotarget. 8(37). 61528–61537. 9 indexed citations
12.
Tseng, Jen‐Chih, et al.. (2016). CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget. 7(25). 38010–38024. 44 indexed citations
13.
Jim, Wai-Tim, Chi‐Jung Chung, Ching‐Yu Lin, et al.. (2015). Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. International Journal of Molecular Sciences. 16(5). 10748–10766. 87 indexed citations
14.
15.
Wang, Chia‐Chen, et al.. (2014). Loss of cell invasiveness through PKC‐mediated syndecan‐1 downregulation in melanoma cells under anchorage independency. Experimental Dermatology. 23(11). 843–849. 10 indexed citations
16.
Lin, Hui‐Ping, Ching‐Yu Lin, Chieh Huo, et al.. (2013). Caffeic Acid Phenethyl Ester as a Potential Treatment for Advanced Prostate Cancer Targeting Akt Signaling. International Journal of Molecular Sciences. 14(3). 5264–5283. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maralee McVean Breakdown of academic impact, for papers by Darryl Johnson Breakdown of academic impact, for papers by Hyung Keun Kim Breakdown of academic impact, for papers by Rouba Hage‐Sleiman Breakdown of academic impact, for papers by Kyung‐Don Kang Breakdown of academic impact, for papers by Munehiro Teranishi Breakdown of academic impact, for papers by Laurent Martin Breakdown of academic impact, for papers by Xiaoxian Gan Breakdown of academic impact, for papers by Zhaohui Meng Breakdown of academic impact, for papers by Maria Fernanda de Souza Costa
Rankless by CCL
2026